Eli Lilly & Co
LLY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000059478
In the last 90 days, Eli Lilly & Co insiders filed 0 open-market purchases and 3 sales; 4,643 institutions reported holding it in 13F filings for Q2 2026, worth $942.7B in total; 4 superinvestors hold it, including ARK Invest and Soros Fund Management.
Holders of 5% or more of LLY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Eli Lilly & Co, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lilly Endowment Inc | 13G/A | 10.10%95.5M shares | 0.00 ppfrom 10.10% | Jan 27, 20253 filings | Oct 30, 2025 | SEC |
| The PNC Financial Services Group, Inc. | 13G/A | 5.39%51.2M shares | – | Feb 7, 20251 filing | Feb 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Eli Lilly & Co, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 20266:02 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −8.55 ppfrom 8.55%Below 5% | Mar 13, 2026 | SEC |
| Oct 30, 20255:34 PM ET | Lilly Endowment Inc | 13G/A | 10.10%95.5M shares | 0.00 ppfrom 10.10% | Sep 30, 2025 | SEC |
| Oct 30, 20252:54 PM ET | Vanguard Group Inc | 13G/A | 8.55%81.0M shares | – | Sep 30, 2025 | SEC |
| Apr 16, 202511:20 AM ET | Lilly Endowment Inc | 13G/A | 10.10%96.0M shares | −0.10 ppfrom 10.20% | Mar 31, 2025 | SEC |
| Feb 7, 20258:52 AM ET | The PNC Financial Services Group, Inc. | 13G/A | 5.39%51.2M shares | – | Dec 31, 2024 | SEC |
| Jan 27, 20253:54 PM ET | Lilly Endowment Inc | 13G/A | 10.20%96.9M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Eli Lilly & Co shares.
No Form 144 notices for Eli Lilly & Co are on file.